Pidotimod
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| ATC code | L03AX05 (WHO) |
| PubChem | CID 65944 |
| ChemSpider |
59348 |
| UNII |
785363R681 |
| KEGG |
D07261 |
| ChEMBL |
CHEMBL1488165 |
| Synonyms | (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid |
| Chemical data | |
| Formula | C9H12N2O4S |
| Molar mass | 244.26758 g/mol |
| |
| |
| | |
Pidotimod is an immunostimulant.[1]
References
- ↑ Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (September 2008). "Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression". Archives of pharmacal research 31 (9): 1153–9. doi:10.1007/s12272-001-1282-6. PMID 18806958.
| ||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
